SysteMHC v.231201
Home Datasets
Explore
Search atlas
Non-UniProt peptides
Statistics
Atlas stats
Allele stats
PTM stats
Download Help About Update

Showing details for project SYSMHC00079



SampleIDNumReplicatesOrganismTissueTypeCellTypeMHCAllele
SampleID
NumReplicates
Organism
TissueType
CellType
MHCAllele
SYSMHC00079_DPrep1 4 Human HLA-DPA10201-DPB10401,HLA-DPA10202-DPB10401
SYSMHC00079_DPrep2 4 Human HLA-DPA10201-DPB10401,HLA-DPA10202-DPB10401
SYSMHC00079_DPrep3 4 Human HLA-DPA10201-DPB10401,HLA-DPA10202-DPB10401
SYSMHC00079_DPrep4 16 Human HLA-DPA10201-DPB10401,HLA-DPA10202-DPB10401
SYSMHC00079_DPrep5 16 Human HLA-DPA10201-DPB10401,HLA-DPA10202-DPB10401
SYSMHC00079_DQrep1 19 Human HLA-DQA10505-DQB10301
SYSMHC00079_DQrep2 6 Human HLA-DQA10505-DQB10301
SYSMHC00079_DQrep3 4 Human HLA-DQA10505-DQB10301
SYSMHC00079_DQrep4 4 Human HLA-DQA10505-DQB10301
SYSMHC00079_DQrep5 6 Human HLA-DQA10505-DQB10301
SYSMHC00079_DQrep6 16 Human HLA-DQA10505-DQB10301
SYSMHC00079_DRrep1 4 Human DRB1_1201,DRB3_0202
SYSMHC00079_DRrep2 8 Human DRB1_1201,DRB3_0202
SYSMHC00079_DRrep3 4 Human DRB1_1201,DRB3_0202
SYSMHC00079_DRrep4 16 Human DRB1_1201,DRB3_0202
SYSMHC00079_DRrep5 15 Human DRB1_1201,DRB3_0202
SYSMHC00079_DRrep6 15 Human DRB1_1201,DRB3_0202
SYSMHC00079_DRrep7 31 Human DRB1_1201,DRB3_0202
Showing 1 to 11 of 18 entries



Detailed view of sample SYSMHC00079_DRrep5



IDSampleIDRawFileNameProcessCulture ConditionsDisease StateCommentsMHCClassPubMed IDPeptideIsolation MethodAntibodyMass SpectrometerLC SystemiRT PeptidesAcquisition ModeFragmentation MethodGradientGradient LengthFlow RateReplicate Number
ID
SampleID
RawFileName
Organism
Process
Tissue Type
Cell Type
Culture Conditions
Disease State
Comments
MHCClass
MHCAllele
PubMed ID
Peptide
Isolation Method
Antibody
Mass Spectrometer
LC System
iRT Peptides
Acquisition Mode
Fragmentation Method
Gradient
Gradient Length
Flow Rate
Replicate Number
SYSMHC00079 SYSMHC00079_DRrep5 DRrep5_A10.raw In vitro suspension EBV transformed class II PXD025877 native Immunoaffinity LB3.1 Q-Exactive no DDA HCD 2-80%(0.1% FA in ACN) 60 250 nL/min 1
SYSMHC00079 SYSMHC00079_DRrep5 DRrep5_A11.raw In vitro suspension EBV transformed class II PXD025877 native Immunoaffinity LB3.1 Q-Exactive no DDA HCD 2-80%(0.1% FA in ACN) 60 250 nL/min 2
SYSMHC00079 SYSMHC00079_DRrep5 DRrep5_A12.raw In vitro suspension EBV transformed class II PXD025877 native Immunoaffinity LB3.1 Q-Exactive no DDA HCD 2-80%(0.1% FA in ACN) 60 250 nL/min 3
SYSMHC00079 SYSMHC00079_DRrep5 DRrep5_A13.raw In vitro suspension EBV transformed class II PXD025877 native Immunoaffinity LB3.1 Q-Exactive no DDA HCD 2-80%(0.1% FA in ACN) 60 250 nL/min 4
SYSMHC00079 SYSMHC00079_DRrep5 DRrep5_A14.raw In vitro suspension EBV transformed class II PXD025877 native Immunoaffinity LB3.1 Q-Exactive no DDA HCD 2-80%(0.1% FA in ACN) 60 250 nL/min 5
SYSMHC00079 SYSMHC00079_DRrep5 DRrep5_A15.raw In vitro suspension EBV transformed class II PXD025877 native Immunoaffinity LB3.1 Q-Exactive no DDA HCD 2-80%(0.1% FA in ACN) 60 250 nL/min 6
SYSMHC00079 SYSMHC00079_DRrep5 DRrep5_A1.raw In vitro suspension EBV transformed class II PXD025877 native Immunoaffinity LB3.1 Q-Exactive no DDA HCD 2-80%(0.1% FA in ACN) 60 250 nL/min 7
SYSMHC00079 SYSMHC00079_DRrep5 DRrep5_A2.raw In vitro suspension EBV transformed class II PXD025877 native Immunoaffinity LB3.1 Q-Exactive no DDA HCD 2-80%(0.1% FA in ACN) 60 250 nL/min 8
SYSMHC00079 SYSMHC00079_DRrep5 DRrep5_A3.raw In vitro suspension EBV transformed class II PXD025877 native Immunoaffinity LB3.1 Q-Exactive no DDA HCD 2-80%(0.1% FA in ACN) 60 250 nL/min 9
SYSMHC00079 SYSMHC00079_DRrep5 DRrep5_A4.raw In vitro suspension EBV transformed class II PXD025877 native Immunoaffinity LB3.1 Q-Exactive no DDA HCD 2-80%(0.1% FA in ACN) 60 250 nL/min 10
SYSMHC00079 SYSMHC00079_DRrep5 DRrep5_A5.raw In vitro suspension EBV transformed class II PXD025877 native Immunoaffinity LB3.1 Q-Exactive no DDA HCD 2-80%(0.1% FA in ACN) 60 250 nL/min 11
SYSMHC00079 SYSMHC00079_DRrep5 DRrep5_A6.raw In vitro suspension EBV transformed class II PXD025877 native Immunoaffinity LB3.1 Q-Exactive no DDA HCD 2-80%(0.1% FA in ACN) 60 250 nL/min 12
SYSMHC00079 SYSMHC00079_DRrep5 DRrep5_A7.raw In vitro suspension EBV transformed class II PXD025877 native Immunoaffinity LB3.1 Q-Exactive no DDA HCD 2-80%(0.1% FA in ACN) 60 250 nL/min 13
SYSMHC00079 SYSMHC00079_DRrep5 DRrep5_A8.raw In vitro suspension EBV transformed class II PXD025877 native Immunoaffinity LB3.1 Q-Exactive no DDA HCD 2-80%(0.1% FA in ACN) 60 250 nL/min 14
SYSMHC00079 SYSMHC00079_DRrep5 DRrep5_A9.raw In vitro suspension EBV transformed class II PXD025877 native Immunoaffinity LB3.1 Q-Exactive no DDA HCD 2-80%(0.1% FA in ACN) 60 250 nL/min 15
Showing 1 to 3 of 15 entries